Works matching IS 09697128 AND DT 2011 AND VI 18 AND IP 12

Results: 13

Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle.

Published in:

Gene Therapy, 2011, v. 18, n. 12, p. 1180, doi. 10.1038/gt.2011.93

By:

Karvinen, H;
Pasanen, E;
Rissanen, T T;
Korpisalo, P;
Vähäkangas, E;
Jazwa, A;
Giacca, M;
Ylä-Herttuala, S

Publication type:

Article

Non-coding RNAs and the advent of new directions in therapeutics.

Published in:

Gene Therapy, 2011, v. 18, n. 12, p. 1103, doi. 10.1038/gt.2011.150

By:

Glorioso, J C

Publication type:

Article

Current progress in the development of RNAi-based therapeutics for HIV-1.

Published in:

Gene Therapy, 2011, v. 18, n. 12, p. 1134, doi. 10.1038/gt.2011.149

By:

Zhou, J;
Rossi, J J

Publication type:

Article

Preclinical development of siRNA therapeutics for AL amyloidosis.

Published in:

Gene Therapy, 2011, v. 18, n. 12, p. 1150, doi. 10.1038/gt.2011.69

By:

Hovey, B M;
Ward, J E;
Soo Hoo, P;
O'Hara, C J;
Connors, L H;
Seldin, D C

Publication type:

Article

Imaging gene delivery in a mouse model of congenital neuronal ceroid lipofuscinosis.

Published in:

Gene Therapy, 2011, v. 18, n. 12, p. 1173, doi. 10.1038/gt.2011.118

By:

Pike, L S;
Tannous, B A;
Deliolanis, N C;
Hsich, G;
Morse, D;
Tung, C-H;
Sena-Esteves, M;
Breakefield, X O

Publication type:

Article

Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle.

Published in:

Gene Therapy, 2011, v. 18, n. 12, p. 1166, doi. 10.1038/gt.2011.66

By:

Karvinen, H;
Pasanen, E;
Rissanen, T T;
Korpisalo, P;
Vähäkangas, E;
Jazwa, A;
Giacca, M;
Ylä-Herttuala, S

Publication type:

Article

The oncolytic adenovirus AdΔΔ enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models.

Published in:

Gene Therapy, 2011, v. 18, n. 12, p. 1157, doi. 10.1038/gt.2011.141

By:

Cherubini, G;
Kallin, C;
Mozetic, A;
Hammaren-Busch, K;
Müller, H;
Lemoine, N R;
Halldén, G

Publication type:

Article

Chemical modification and design of anti-miRNA oligonucleotides.

Published in:

Gene Therapy, 2011, v. 18, n. 12, p. 1111, doi. 10.1038/gt.2011.100

By:

Lennox, K A;
Behlke, M A

Publication type:

Article

Developing therapeutic microRNAs for cancer.

Published in:

Gene Therapy, 2011, v. 18, n. 12, p. 1121, doi. 10.1038/gt.2011.79

By:

Bader, A G;
Brown, D;
Stoudemire, J;
Lammers, P

Publication type:

Article

MicroRNA therapeutics.

Published in:

Gene Therapy, 2011, v. 18, n. 12, p. 1104, doi. 10.1038/gt.2011.50

By:

Broderick, J A;
Zamore, P D

Publication type:

Article

Using non-coding small RNAs to develop therapies for Huntington's disease.

Published in:

Gene Therapy, 2011, v. 18, n. 12, p. 1139, doi. 10.1038/gt.2011.170

By:

Zhang, Y;
Friedlander, R M

Publication type:

Article

Special delivery: targeted therapy with small RNAs.

Published in:

Gene Therapy, 2011, v. 18, n. 12, p. 1127, doi. 10.1038/gt.2011.56

By:

Peer, D;
Lieberman, J

Publication type:

Article

Targeting gene expression to cones with human cone opsin promoters in recombinant AAV.

Published in:

Gene Therapy, 2011, v. 18, n. 12, p. 1179, doi. 10.1038/gt.2011.156

By:

Komáromy, A M;
Alexander, J J;
Cooper, A E;
Chiodo, V A;
Acland, G M;
Hauswirth, W W;
Aguirre, G D

Publication type:

Article